ACIU
ACIU
Positions held
Your positionsACIU isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · INSM Stock Slides on CFO Exit, Reiterates '26 Sales View
2026-10-06 · AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know
2026-10-06 · PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal
2026-10-05 · Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
2026-10-05 · Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation
2026-10-05 · Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work
2026-10-01 · UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
2026-10-01 · Novo's Wegovy Pill Shows Weight Loss After Switching From Injections
2026-10-01 · Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study
2026-09-30 · NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk
2026-09-30 · uniQure Plunges on Additional Data From Huntington's Disease Study
2026-09-30 · IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026
Price (daily)
Full chart · RSI · MACD · patterns